Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial

  1. Steg, P.G.
  2. Bhatt, D.L.
  3. James, S.K.
  4. Darlington, O.
  5. Hoskin, L.
  6. Simon, T.
  7. Fox, K.M.
  8. Leiter, L.A.
  9. Mehta, S.R.
  10. Harrington, R.A.
  11. Himmelmann, A.
  12. Ridderstråle, W.
  13. Andersson, M.
  14. Bueno, H.
  15. De Luca, L.
  16. Tank, A.
  17. Mellström, C.
  18. McEwan, P.
Journal:
European heart journal. Cardiovascular pharmacotherapy

ISSN: 2055-6845

Year of publication: 2022

Volume: 8

Issue: 8

Pages: 777-785

Type: Article

DOI: 10.1093/EHJCVP/PVAC032 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus